Efficacy News and Research

RSS
FDA approves first oral medication for treatment of adults with Fabry disease

FDA approves first oral medication for treatment of adults with Fabry disease

FDA approves first vaginal ring contraceptive that can be used for one year

FDA approves first vaginal ring contraceptive that can be used for one year

FDA approves first targeted RNA-based treatment for rare, fatal genetic disease

FDA approves first targeted RNA-based treatment for rare, fatal genetic disease

Initiation of PIMs associated with higher risk of fracture-specific hospitalizations and mortality

Initiation of PIMs associated with higher risk of fracture-specific hospitalizations and mortality

New discovery could pave way for improved leukemia treatment

New discovery could pave way for improved leukemia treatment

Cleveland Clinic awarded $4.7 million grant to study prevention of cancer-associated blood clots

Cleveland Clinic awarded $4.7 million grant to study prevention of cancer-associated blood clots

New drug delivery system delivers anticancer drugs that reduce tumor size

New drug delivery system delivers anticancer drugs that reduce tumor size

New review examines potential of medicinal cannabis to help treat intractable epilepsy

New review examines potential of medicinal cannabis to help treat intractable epilepsy

Saving sight of millions by making eye injections safe and comfortable

Saving sight of millions by making eye injections safe and comfortable

FDA issues scientific recommendations to encourage development of novel drugs for treatment of OUD

FDA issues scientific recommendations to encourage development of novel drugs for treatment of OUD

Regenacy Pharmaceuticals partners with CMTA to advance ricolinostat for treating hereditary neuropathy

Regenacy Pharmaceuticals partners with CMTA to advance ricolinostat for treating hereditary neuropathy

Otsuka’s JINARC approved for treatment of patients with CKD stage 4 ADPKD

Otsuka’s JINARC approved for treatment of patients with CKD stage 4 ADPKD

Scientists develop simple, innovative method to convert white fat to brown fat

Scientists develop simple, innovative method to convert white fat to brown fat

RBC-hitchhiking method increases concentration of drugs ferried to selected organs

RBC-hitchhiking method increases concentration of drugs ferried to selected organs

New drug cocktails make targeted cancer therapies more efficient with less side effects

New drug cocktails make targeted cancer therapies more efficient with less side effects

Catalytic nanoparticles can effectively prevent tooth decay

Catalytic nanoparticles can effectively prevent tooth decay

Researchers engineer three cell lines to produce nonproprietary versions of NISTmAb

Researchers engineer three cell lines to produce nonproprietary versions of NISTmAb

New discovery may lead to targeted treatment for copper metabolism disorders

New discovery may lead to targeted treatment for copper metabolism disorders

Glaucoma Research Foundation-funded research makes breakthrough in treatment of glaucoma

Glaucoma Research Foundation-funded research makes breakthrough in treatment of glaucoma

European Commission approves Pfizer’s first oncology biosimilar

European Commission approves Pfizer’s first oncology biosimilar

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.